Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

363 results about "Iron-deficiency anemia" patented technology

Iron deficiency anemia is a common type of anemia — a condition in which blood lacks adequate healthy red blood cells.

Coarse-cereal dried bean curd roll and preparation method thereof

The invention relates to a coarse-cereal dried bean curd roll and a preparation method thereof. The coarse-cereal dried bean curd roll is a bean product which is made by raw materials such as 45-85 percent of soy beans, 10-35 percent of black beans, 5-30 percent of green beans, 0-20 percent of peanuts and the like through steps of soaking, pulp grinding, pulp stewing, roll formation and drying. The coarse-cereal dried bean curd roll contains rich nutrients in various coarse cereals such as the black beans, the soy beans, the green beans and the peanuts, is rich in various vitamins, dietary fibers and minerals such as calcium, iron and the like and can promote the balance of dietary nutrition of people; when people eat the coarse-cereal dried bean curd roll for a long term, the effects of promoting blood circulation, reducing cholesterol, improving mental function, complementing calcium, preventing osteoporosis, preventing iron-deficiency anemia and the like can be achieved; the coarse-cereal dried bean curd roll is dark yellow and glossy, the rolls are even, the rehydration performance is good, the taste is flexible and unique, the roll is fragrant to taste and the aftertaste is long; and the yield of the process is high, the quality of the obtained product is high, the production cost is lower and the economic benefit is considerable.
Owner:安阳市双强豆制品有限公司

Double-layer sustained release tablets for compensating iron and preparation thereof

The invention relates to a double-layer sustained release tablet for supplementing iron, the double-layer sustained release tablet consists of a sustained release layer and a quick release layer laminating with each other at the weight ratio of 1:0.25-1:4; the sustained release layer consists of an iron-containing compound, a sustained release framework, an adhesive, a lubricant and a filler; the quick release layer consists of a traditional Chinese medicine for enriching the blood and/or invigorating vital energy, a filler, a disintegrating agent, an adhesive and a lubricant; the quick release layer can also be added with vitamins. In the double-layer sustained release tablet, by arranging the iron-containing compound in the sustained release layer and the traditional Chinese medicine in the quick release layer, the iron element is released slowly and uniformly, which increases the absorption rate, avoids gastrointestinal reaction caused by high-content iron; meanwhile the double-layer sustained release tablet supplements iron element and the traditional Chinese medicine which has the functions of enriching the blood and invigorating vital energy, thus fully improving the nutritional status caused by iron deficiency anemia and improving iron supplementing effect.
Owner:BEIJING COMPETITOR SPORTS SCI & TECH

Iron supplement composition, its preparing method and application of the same

The invention discloses a pharmaceutical composition as an iron supplement agent, which comprises ferrous glycinate, antioxidant and medicinal carrying agents. The invention also discloses preparations containing the composition, the process for preparing the composition and the preparations, and the use of the composition in preventing and treating iron deficiency. The composition is capable of appreciably improving the absorption ratio of iron in intestinal tract, thereby improving iron-deficiency anemia effectively.
Owner:内蒙古百金纳投资有限责任公司 +1

Patches and methods for the transdermal delivery of a therapeutically effective amount of iron

ActiveUS20100130912A1Preventing and/or treating an iron deficiency in an individualTreating and/or preventing an iron deficiencyOrganic active ingredientsHeavy metal active ingredientsPhysiologyIron-deficiency anemia
Embodiments of the invention provide patches for the transdermal delivery of iron-containing compositions to an individual suffering from an iron deficiency. Many embodiments provide an iontophoretic patch for the transdermal delivery of a therapeutically effective amount of iron. The patch comprises an electrode and a reservoir containing a composition comprising ionic iron for the delivery of the therapeutically effective amount of iron. Various embodiments provide methods of using embodiments of the iontophoretic patch for delivering a therapeutically effective amount of iron to an individual suffering from one more forms of iron deficiency including iron deficiency anemia. Such methods can be used for treating and / or preventing the iron deficiency. The amount of delivered iron can be adjusted depending upon various treatment parameters such as patient weight and type and amount of iron deficiency.
Owner:FE3 MEDICAL

Sodium iron chlorophyllin-chitosan/sodium alginate microcapsules and preparation method thereof

The invention discloses sodium iron chlorophyllin-chitosan/sodium alginate microcapsules and a preparation method thereof. In the method, chitosan/sodium alginate is used as a capsule material, sodium iron chlorophyllin is used as capsule content, and the sodium iron (II) chlorophyllin is microencapsulated by an emulsification-gel method. The preparation method comprises: dissolving sodium iron chlorophyllin in sodium alginate solution at a certain concentration, adding the prepared solution in vegetable oil containing Span-60, and stirring at high steep and emulsifying for 20 minutes; dripping acetic acid aqueous solution containing 2.0-percent chitosan and calcium chloride, continuously stirring for 30 minutes, standing for 2 hours and removing an oil phase; and washing the microcapsules with petroleum ether and isopropanol for three times respectively, performing suction-filtration, and drying at room temperature to obtain the sodium iron chlorophyllin-chitosan/sodium alginate microcapsules. The chitosan which is a natural polysaccharide with high biocompatibility and biodegradability and the sodium alginate serve as sustained and controlled release agent and targeting preparation, the sodium iron chlorophyllin is encapsulated in the center of the microcapsules to be protected from instability caused by change in a light or placing condition, a new formulation is provided in pharmacy, and the microcapsules are suitable to be further developed and used as iron-supplying health-care food and new medicinal preparation for treating iron-deficiency anemia, and have a bright application prospect.
Owner:NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY

Ferrous bisglycinate chelate nutritional composition and application thereof

The invention discloses a ferrous bisglycinate chelate nutritional composition and application thereof. The composition comprises the following active components in percentage by weight: 1.0-89.5% of ferrous bisglycinate chelate, 0.5-20.6% of active polypeptide, 0.4-21.0% of oligosaccharide and 4.0-89.5% of grease. Compared with the compound preparation merely using ferrous bisglycinate chelate and antioxidant, the absorption rate of the nutritional composition of the invention is improved by 20-30%; at the same time, the natural and healthy composition has good smell and good safety. In addition, the composition is rich in peptide and folic acid, thereby being beneficial to growing development for red blood cells. The ferrous bisglycinate chelate nutritional composition of the invention has the characteristics of stability, safety and high bioavailability and has obvious effect for preventing and improving iron-deficiency anemia.
Owner:联合康药(亚洲)有限公司

Preparation method of super-micro molecular iron dextran

The invention discloses a method for preparing super-micro molecular iron dextran by using super-micro molecular dextran (a weight-average molecular weight being 3,000-6,000Da) as a raw material. After the super-micro molecular dextran is subjected to oxidation, complexing, desalting, concentration preparation, filtration and encapsulation sterilization, an iron dextran injection product with an iron content of 25-250 mg/ml can be obtained, and the super-micro molecular iron dextran can be used for preventing and treating the iron-deficiency anemia of piglets and livestocks. According to the method for preparing the super-micro molecular iron dextran, a conventional potassium cyanide method and an alkali method are replaced by adopting oxydol/aqueous alkali oxidation, and a sodium hypochlorite method is improved; an alcohol precipitation method is replaced by using an electric dialyser method to remove the sodium chloride in iron dextran solution; simultaneously, the impurity removal working procedure of an intermediate product is further omitted; the production cost is decreased; the energy consumption is decreased; the production period is shortened; the toxicity is decreased; the emission of waste gas, waste water and industrial residues is reduced; the environmental pollution is reduced; and the production potential safety hazard caused by the usage of flammable and explosive alcohol is eliminated.
Owner:GUANGXI RES INST OF CHEM IND CO LTD

Preparation method for sanguinolaria blood-enriching product

The invention discloses a preparation method for a sanguinolaria blood-enriching product. The blood-enriching product is produced by using abundant heme iron in sanguinolaria; aimed targets are iron-deficiency anemia patients; the products comprise blood-enriching oral solutions, blood-enriching capsules, blood-enriching granules, blood-enriching electuaries, blood-enriching tablets and the like; further processing is carried out so that the problems of an existing method for eating the sanguinolaria that damages to a human body are great, heavy metal exceeds the standards, and deep processing is lacked are solved well. The sanguinolaria blood-enriching product has a good blood-enriching effect; the absorption utilization is up to be more than 25%; the safety of the blood-enriching product is higher than that of a blood-enriching preparation prepared from terrestrial animal blood; the sanguinolaria can remove a large part of shell toxins and the internal heavy metal in a temporary rearing process; a biological enzymolysis process is used for degrading macromolecular proteins in the sanguinolaria into micro-molecular protein peptides which are easily absorbed by a human body; beta-cyclodextrine is added into enzymatic hydrolysate so that the fishy smell and the bitter taste of the sanguinolaria enzymatic hydrolysate can be buried, and consumers can commonly accept the product.
Owner:赵祥忠
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products